A parent's view... keeping children active
Kat Earley's son Cohen was diagnosed with rhabdomyosarcoma, aged four. She writes about how staying active wherever possible played a crucial role in his wellbeing both during and after treatment.
Kat Earley's son Cohen was diagnosed with rhabdomyosarcoma, aged four. She writes about how staying active wherever possible played a crucial role in his wellbeing both during and after treatment.
Saskia Wells was diagnosed with a brain tumour, aged 16. Now 18, she tells us about being one of the first patients in the UK to receive one-to-one exercise therapy support through the Active Hospitals project, funded by Public Health England and Sport England, at Sheffield Children’s Hospital.
Debbi Rowley (left) and Lucy Waller (right) are physiotherapists at Sheffield Children’s Foundation Trust and Great Ormond Street Hospital, respectively. Here, they offer advice on things to consider before starting physical activity and tell us about some of the initiatives happening across the UK to help children with cancer move more.
Promoting physical activity in childhood cancer survivors: Using qualitative and co-design methods to inform the development of an evidence-based intervention.
Dr Peter Wright, Hayley Marriott and Dr Alba Solera-Sanchez, researchers at Oxford Brookes University, explain the benefits of staying physically active during and after treatment and explore how we can work collaboratively to improve physical activity pathways and support for children and young people.
Jake Heasman was diagnosed with a brain tumour when he was two years old, leaving him visually impaired. He tells us how his experiences of cancer helped drive him on to sporting success.
Ask the expert with Dr Ren Manias, Consultant Paediatric Oncologist at Southampton General Hospital, and Contact's medical adviser
Dr Peppy Brock is a retired consultant paediatric oncologist. She explains how a dedicated international group of medical professionals helped improve survival and reduce toxicity for a very rare type of childhood cancer.
At the Fisher Lab at UCL, we are trying to find a better treatment that specifically attacks osteosarcoma cells, to better fight cancer and reduce the burden of side effects. We think that immunotherapy could be the right treatment because it trains cells from the immune system, called T Cells, to fight cancer and has been very successful in other cancers.